Telecardiology in the monitoring after percutaneous alcohol septal ablation of obstructive hypertrophic cardiomyopathy

被引：0
|
作者：
Moltrasio, M [1 ]
Cozzi, S [1 ]
Berna, G [1 ]
Galli, S [1 ]
Doria, E [1 ]
Polvani, GL [1 ]
Famoso, G [1 ]
Borghini, E [1 ]
Fassini, G [1 ]
Bartorelli, AL [1 ]
机构：
[1] Univ Milan, Inst Cardiol, IRCCS, Ctr Cardiol Monzino, Milan, Italy
来源：
HEART DISEASE: NEW TRENDS IN RESEARCH, DIAGNOSIS AND TREATMENT | 2001年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Percutancous transluminal septal myocardial ablation (PTSMA) is an alternative therapeutical procedure for patients with severe hypertrophic cardiomiopathy. Alcohol injection may cause arrhythmias and conduction disturbances, even several days after the procedure; this suggests prolonged hospital monitoring. Aim of our study was to evaluate feasibility and usefulness of "telecardiology" after PTSMA for a reduction of hospital stay and a safer hospital discharge.
引用
收藏
页码：479 / 482
页数：4
相关论文
共 50 条
  • [21] Alcohol Septal Ablation in a Patient With Hypertrophic Obstructive Cardiomyopathy
    Agarwal, Shvetank
    Puri, Suvikram
    Wang, Hong
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2014, 28 (02) : 350 - 354
  • [22] Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
    Yang, Qiulan
    Zhu, Changsheng
    Cui, Hao
    Tang, Bing
    Wang, Shengwei
    Yu, Qinjun
    Zhao, Shihua
    Song, Yunhu
    Wang, Shuiyun
    JOURNAL OF THORACIC DISEASE, 2021, 13 (02) : 1055 - 1065
  • [23] Effect of metoprolol in hypertrophic obstructive cardiomyopathy patients after alcohol septal ablation
    Hnatova, Hana
    Fulinova, Klara
    Rihakova, Barbora
    Bonaventura, Jiri
    Veselka, Josef
    IJC HEART & VASCULATURE, 2023, 49
  • [24] Sex and outcomes after alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy
    Nagueh, Sherif F.
    HEART, 2022, 108 (20) : 1588 - 1589
  • [25] Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy
    Runquist, LH
    Nielsen, CD
    Killip, D
    Gazes, P
    Spencer, WH
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (09): : 1020 - +
  • [26] Outcome of elderly patients after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    Jahnlova, D.
    Tomasov, P.
    Veselka, J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 367 - 367
  • [27] Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy
    Yuan, J. S.
    Qiao, S. B.
    You, S. J.
    Gao, R. L.
    Duan, F. J.
    Tian, Y. Q.
    Yang, W. X.
    Hu, F. H.
    Chen, J. L.
    CARDIOLOGY, 2009, 114 : 120 - 121
  • [28] Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy
    Liu, Liwen
    Li, Jing
    Zuo, Lei
    Zhang, Jinzhou
    Zhou, Mengyao
    Xu, Bo
    Hahn, Rebeccca T.
    Leon, Martin B.
    Hsi, David H.
    Ge, Junbo
    Zhou, Xiaodong
    Zhang, Jun
    Ge, Shuping
    Xiong, Lize
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : 1898 - 1909
  • [29] Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring
    Faber, L
    Ziemssen, P
    Seggewiss, H
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2000, 13 (12) : 1074 - 1079
  • [30] Outcome of percutaneous septal ethanol ablation for obstructive hypertrophic cardiomyopathy
    Sorajja, Paul
    Valeti, Uma
    Nishimura, Rick A.
    Ommen, Steve R.
    Rihal, Charanjit S.
    Holmes, David R., Jr.
    CIRCULATION, 2007, 116 (16) : 357 - 357
12345